fbpx

Female, 46 y/o

Patient internal ID: 75731448

ICD-10 code

C50.9 Malignant Neoplasm of Breast of Unspecified Site

Diagnosis (incl metastases/stage) and year

March 2019
Right Breast Carcinoma cT3N1M1 G2, ER+, PR+, HER2(-), BRCA2+ stage IV. Multiple Metastases to Bone, Lung. Disease progression in June 2020 – Metastases in Liver.

Previous treatment

Radiation Therapy, Target Therapy (Denozumab), Hormone Therapy (Tamoxifen), Hormone Therapy (Gosselin), Chemotherapy (Paclitaxel), Chemotherapy (Capecitabine), Chemotherapy (Carboplatin).

Prognosis and survival expectation

The prognosis remains poor for Advanced Breast Cancer, with a median survival of around 32 months from diagnosis.

Treatment provided

Autologous DCV (1 dose) and CIK (4 doses) over a period of 3 months

Patient survival/condition and year

The patient survived for 21 months from the diagnosis. The patient passed away during the Immunotherapy treatment and did not finish the full treatment schedule. Therefore, no conclusions can be made regarding the effectiveness of the treatment.

Date of Review

30/12/2023